Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Supervisor Dorsey introduces ordinance to require retail pharmacies to stock buprenorphine, citing DPH survey showing limited local availability
Summary
Supervisor Dorsey introduced legislation on May 14 to require all retail pharmacies in San Francisco to stock buprenorphine, a medication for opioid use disorder, after Department of Public Health survey results showed fewer than half of responding pharmacies could immediately fill a two‑week prescription.
Supervisor Dorsey introduced legislation on May 14 that would require all retail pharmacies in San Francisco to maintain a stock of buprenorphine, a medication used in treatment for opioid use disorder that reduces withdrawal, cravings and overdose risk.
Why it matters: Supporters said easier, rapid access to buprenorphine can save lives and expand medically assisted treatment without the delays that sometimes drive people back to illicit, potentially lethal substances. The supervisor framed the measure as a local step to increase access after…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
